跳至主要内容
临床试验/TCTR20210618003
TCTR20210618003已完成4 期

An efficacy of high-power optically pumped semiconductor laser (HOPSL) 577 nanometers in the treatment of melasma, A pilot study

Siriraj Skin Laser Center0 个研究点目标入组 19 人开始时间: 2021年6月18日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
19

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 Years 至 65 Years(—)
性别
All

入选标准

  • 1. Age 20-65 years old
  • 2. Melasma (Epidermal or mixed type) on both side of face
  • 3. Do not response to at least 2% hydroquinone-containing regimen after at least 3 months usage
  • 4. Fizpatrick skin type III-V
  • 5. Willing to participate and give written informed consent

排除标准

  • 1. Pregnancy or lactation
  • 2. Dermatitis or wound on face
  • 3. Has other type(s) of pigmented lesions (such as seborrheic keratosis, lentigines, freckles, Hori's nevus, or nevus of Ota) in the melasma area
  • 4. History of hormonal treatment within 1 month before the study participation
  • 5. Recieve any chemical peelings or laser treatment on the face within 6 months before the study participation

研究者

发起方
Siriraj Skin Laser Center

相似试验